`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`NOVO NORDISK INC. and
`NOVO NORDISK A/S,
`
`Plaintiffs,
`
`v C.A. No. 22-cv-936-CFC
`
`BIOCON PHARMA LTD., BIOCON LTD.,
`and BIOCON PHARMA, INC.,
`
`Defendants.
`
`N N N N N N N N N N N
`
`BIOCON’S DISCLOSURE STATEMENT
`
`Pursuant to Fed. R. Civ. P. 7.1, Defendants Biocon Pharma, Inc., Biocon Pharma Limited,
`
`and Biocon Limited, through their undersigned counsel, state as follows:
`
`1) Biocon Pharma, Inc. is a wholly owned subsidiary of Biocon Pharma Limited;
`2) Biocon Pharma Limited is a wholly owned subsidiary of Biocon Limited; and
`3) Biocon Limited has no parent corporation and no publicly-held corporation owns
`
`more than 10% of its stock.
`
`Dated: September 23, 2022
`
`Kenneth L. Dorsney (#3726)
`
`OF COUNSEL: Cortlan S. Hitch (#6720)
`MORRIS JAMES LLP
`Deepro R. Mukerjee 500 Delaware Avenue, Suite 1500
`Lance Soderstrom Wilmington, DE 19801
`KATTEN MUCHIN ROSENMAN LLP (302) 888-6800
`50 Rockefeller Plaza kdorsney@morrisjames.com
`New York, NY 10020-1605 chitch@morrisjames.com
`
`deepro.mukerjee@katten.com
`lance.soderstrom@katten.com
`
`
`
`
`
`
`
`
`Case 1:22-cv-00936-CFC Document 14
`
`Jitendra Malik Ph.D.
`
`KATTEN MUCHIN ROSENMAN LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`
`(704) 444-2000
`
`jitty. malik@katten.com
`
`Matthew M. Holub
`
`KATTEN MUCHIN ROSENMAN LLP
`525 West Monroe Street
`
`Chicago, IL 60661-3693
`
`(312) 902-5200
`matthew.holub@katten.com
`
`Filed 09/23/22
`
`Page 2 of 2 PagelD #: 120
`
`
`
`
`
`
`
`
`



